Shreyas Interm.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE115F01017
  • NSEID:
  • BSEID: 526335
INR
7.30
0.13 (1.81%)
BSENSE

Mar 05

BSE+NSE Vol: 203

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

203 (-87.81%) Volume

Shareholding (Dec 2025)

FII

8.39%

Held by 1 FIIs

DII

0.00%

Held by 1 DIIs

Promoter

57.21%

Who are in the management team of Shreyas Interm.?

06-Jun-2025

As of March 2022, the management team of Shreyas Interm. includes Govind Krishna Sharma (Independent Director), Surya Prakash Pandey (Whole-time Director), Neelam Yashpal Arora (Independent Director), Bhavesh Vrujlal Gondaliya (Company Secretary & Compliance Officer), Dinesh Shankarlal Sharma (Non-Executive Director), and Nainesh Sumanti Rai Desai (Independent Director).

As of March 2022, the management team of Shreyas Interm. includes the following individuals:<BR><BR>1. Govind Krishna Sharma - Independent Director<BR>2. Surya Prakash Pandey - Whole-time Director<BR>3. Neelam Yashpal Arora - Independent Director<BR>4. Bhavesh Vrujlal Gondaliya - Company Secretary & Compliance Officer<BR>5. Dinesh Shankarlal Sharma - Non-Executive Director<BR>6. Nainesh Sumanti Rai Desai - Independent Director<BR><BR>These members play various roles within the company's governance and management structure.

View full answer

Has Shreyas Interm. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Shreyas Interm.?

03-Jun-2025

Shreyas Interm.'s peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex. In terms of returns, India Glycols leads with 150.27% over one year, while Shreyas Interm. has a return of -9.56%.

Peers: The peers of Shreyas Interm. are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar and Sh. Hari Chem., and Average management risk is noted at Tata Chemicals and India Glycols. Below Average management risk is present at Fischer Medical and Camex, while Gayatri BioOrga., Genus Prime, and Shreyas Interm. do not qualify. Growth is Good at Sh. Hari Chem., while Below Average growth is seen at Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, and Camex. Average growth is noted at Fischer Medical, and the rest do not qualify. Capital Structure is Excellent at GHCL, Good at Fischer Medical, Average at Tata Chemicals, and Below Average at Chemplast Sanmar, India Glycols, Sh. Hari Chem., and Camex, while the rest do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.27%, while the lowest is Tata Chemicals at -14.63%. Shreyas Interm.'s 1-year return is -9.56%, which is higher than Tata Chemicals but lower than the majority of its peers. Additionally, Camex and Tata Chemicals have negative six-month returns.

View full answer

Is Shreyas Interm. overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Shreyas Interm. is considered risky and overvalued due to negative earnings and unfavorable financial metrics, including a PE ratio of -42.92, while its year-to-date performance shows a decline of 23.72% compared to the Sensex's gain of 5.65%.

As of 25 April 2023, the valuation grade for Shreyas Interm. has moved from does not qualify to risky, indicating a significant change in its perceived financial health. The company appears to be overvalued based on its current metrics, with a PE ratio of -42.92, an EV to EBITDA of -75.07, and a Price to Book Value of 3.95. These ratios highlight the company's struggles, particularly with negative earnings and returns on capital employed and equity, which stand at -8.56% and -9.20%, respectively.<BR><BR>In comparison to its peers, Shreyas Interm. is positioned unfavorably against companies like Sudarshan Chemicals, which has a PE ratio of 71.32, and Kiri Industries, with a PE ratio of 13.72. This stark contrast further emphasizes the overvaluation of Shreyas Interm. Additionally, while the stock has shown a positive return of 3.85% over the past week compared to the Sensex's 1.45%, its year-to-date performance is concerning, with a decline of 23.72% against the Sensex's gain of 5.65%. Overall, the financial indicators suggest that Shreyas Interm. is overvalued in the current market environment.

View full answer

What is the technical trend for Shreyas Interm.?

09-Jun-2025

As of June 4, 2025, Shreyas Interm. shows a mildly bearish trend overall, with mixed signals from various indicators, including a mildly bullish weekly MACD and bearish monthly MACD.

As of 4 June 2025, the technical trend for Shreyas Interm. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST indicates a mildly bullish trend weekly, but is mildly bearish monthly. Overall, the indicators present a mildly bearish stance with some mixed signals, particularly in the weekly timeframe.

View full answer

What does Shreyas Interm. do?

17-Jul-2025

Shreyas Intermediates Ltd manufactures dyes, pigments, and pigment intermediates in the Commodity Chemicals industry. As of March 2025, it reported a net profit of -3 Cr and has a market cap of INR 70 Cr.

Overview: <BR>Shreyas Intermediates Ltd is engaged in the manufacturing of Dyes, Pigments, and Pigment Intermediates within the Commodity Chemicals industry and operates as a Micro Cap company.<BR><BR>History: <BR>Shreyas Intermediates Ltd was incorporated as a Private Limited Company on November 6, 1989, and was converted into a Public Limited Company in April 1992. The latest quarterly results reported a net profit of -3 Cr for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: -3 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 70 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.45 <BR>Return on Equity: -9.20% <BR>Price to Book: 4.04<BR><BR>Contact Details: <BR>Address: D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722 <BR>Tel: 91-2356-272471 <BR>Email: accounts@shreyasintermediates.com <BR>Website: http://www.shreyaintermediates.co.in

View full answer

Who are the top shareholders of the Shreyas Interm.?

17-Jul-2025

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited with 27.59%, Invent Assets Securitisation And Reconstruction Pvt Ltd at 24.7%, and foreign institutional investors holding 8.53%. Promoter holdings are partially pledged at 10.028%.

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited, which holds the highest promoter stake at 27.59%. Additionally, the highest public shareholder is Invent Assets Securitisation And Reconstruction Pvt Ltd, with a holding of 24.7%. The company also has foreign institutional investors (FIIs) holding 8.53%, while individual investors account for 7.67% of the shares. Promoter holdings are partially pledged at 10.028%.

View full answer

How big is Shreyas Interm.?

24-Jul-2025

As of 24th July, Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr and reported net sales of 0.00 Cr with a net loss of 1.57 Cr over the last four quarters. Shareholder's funds are valued at 17.98 Cr, and total assets amount to 25.76 Cr.

As of 24th July, <BR><BR>Market Cap: Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.00 Cr, while the sum of Net Profit for the same period shows a loss of 1.57 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period ending March 2024. Shareholder's Funds are valued at 17.98 Cr, and Total Assets amount to 25.76 Cr.

View full answer

When is the next results date for Shreyas Interm.?

07-Nov-2025

Shreyas Interm. will declare its results on 14 November 2025.

Shreyas Interm. will declare its results on 14 November 2025.

View full answer

How has been the historical performance of Shreyas Interm.?

03-Dec-2025

Shreyas Interm. has consistently reported zero net sales and persistent losses from March 2019 to March 2025, with negative operating profits and declining book value per share, indicating ongoing financial struggles and lack of revenue generation. Total liabilities and assets have also decreased during this period.

Answer:<BR>The historical performance of Shreyas Interm. shows consistent figures across several key financial metrics, primarily indicating a lack of operational revenue and persistent losses over the years.<BR><BR>Breakdown:<BR>Shreyas Interm. has reported zero net sales and other operating income from March 2019 to March 2025, resulting in total operating income remaining at 0.00 throughout this period. The company has incurred minimal employee costs, which have slightly increased from 0.00 in March 2019 to 0.02 in March 2025, while other expenses have fluctuated, peaking at 0.54 in March 2020 before declining to 0.39 in March 2023 and 0.39 in March 2025. Operating profit (PBDIT) has been negative, with losses ranging from -0.17 in March 2019 to -0.41 in March 2025. Profit before tax and profit after tax have also shown consistent losses, with figures of -1.59 in March 2025, reflecting a trend of increasing losses over the years. The company's total liabilities decreased from 31.64 in March 2020 to 24.66 in March 2025, while total assets followed a similar downward trend, falling from 31.64 to 24.66 in the same period. The book value per share has also declined from 2.82 in March 2020 to 1.75 in March 2025, indicating a deterioration in shareholder value. Overall, Shreyas Interm. has struggled with profitability and asset management, maintaining a stagnant operational status with no revenue generation.

View full answer

Are Shreyas Intermediates Ltd latest results good or bad?

14-Feb-2026

Shreyas Intermediates Ltd's latest results are concerning, with zero revenue in Q3 FY26, a 100% decline from the previous quarter, and a net loss of ₹0.39 crores, reflecting significant operational challenges and making it a high-risk investment.

Shreyas Intermediates Ltd's latest results are concerning and can be classified as bad. In the third quarter of FY26, the company reported zero revenue generation, a stark decline from ₹10.37 crores in the previous quarter, marking a 100% sequential drop. This operational paralysis indicates severe challenges in maintaining production and sales.<BR><BR>Additionally, the company recorded a net loss of ₹0.39 crores, which is a 62.5% increase in losses compared to the previous quarter. The return on equity stands at a negative 7.84%, highlighting the company's inability to generate positive returns for shareholders. <BR><BR>Overall, the financial performance reflects significant operational difficulties, with a troubling pattern of intermittent revenue generation and consistent losses. The lack of clear strategies for recovery further exacerbates the situation, making it a high-risk investment.

View full answer

Should I buy, sell or hold Shreyas Intermediates Ltd?

15-Feb-2026

Why is Shreyas Intermediates Ltd falling/rising?

04-Mar-2026

As of 04-Mar, Shreyas Intermediates Ltd's stock price is at 7.17, down 4.91%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with a year-to-date decline of 26.08%, and investor interest appears to be waning.

As of 04-Mar, Shreyas Intermediates Ltd's stock price is falling, currently at 7.17, which reflects a decrease of 0.37 or 4.91%. This decline is evident as the stock has underperformed its sector by 2.06% today and has fallen after three consecutive days of gains. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>The stock's performance over various periods also highlights its struggles, with a year-to-date decline of 26.08%, significantly worse than the Sensex's drop of 7.16%. Over the past year, Shreyas Intermediates Ltd has decreased by 18.52%, while the Sensex has increased by 8.39%. Furthermore, the stock is close to its 52-week low, just 3.77% above a low of Rs 6.9.<BR><BR>Investor participation appears to be declining, with delivery volume on February 27 falling by 88.37% compared to the 5-day average, suggesting reduced interest in trading the stock. The overall action in the Dyes & Pigments sector has also been negative, with a drop of 2.84%. These factors collectively contribute to the current downward movement in the stock price of Shreyas Intermediates Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate 2.20% of over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2

Flat results in Dec 25

3

Risky - Negative EBITDA

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 52 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

21

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

-8.03%

stock-summary
Price to Book

3.21

Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-32.22%
0%
-32.22%
6 Months
-11.84%
0%
-11.84%
1 Year
-15.02%
0%
-15.02%
2 Years
-30.48%
0%
-30.48%
3 Years
12.83%
0%
12.83%
4 Years
-5.32%
0%
-5.32%
5 Years
17.17%
0%
17.17%

Shreyas Interm. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Feb-2026 | Source : BSE

Newspaper cuttings in connection with the UFR for the quarter ended 31.12.2025 in terms of Regulation 30 & 47 of SEBI (LODR) Regulations 2015.

Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting For Meeting Held On 13.02.2026

13-Feb-2026 | Source : BSE

In terms of Regulations 30 and 33(3) of SEBI (LODR) Regulations 2015 this is to inform that the Meeting of the Board of Directors of the Company was held today on 13th February 2026 Friday at the registered office of the Company at 4:00 p.m. and concluded at around 05.00 p.m. The Board inter-alia considered and approved the following matters. 1.The Unaudited Standalone Financial Results for the quarter and nine months ended 31st December 2025 along with Limited Review Report thereon pursuant to Regulation 33 of SEBI (LODR) Regulations 2015. 2.Took note on Compliances made under SEBI (LODR) Regulation 2015 for the quarter and nine months ended 31st December 2025.

Standalone Unaudited Financial Result For Quarter And Nine Months Ended 31.12..2025

13-Feb-2026 | Source : BSE

Pursuant to provision of Regulation 30 raed with Regulation 33 of SEBI (LODR) Regulations 2015 it is hereby informed that the Board of Directors in its meeting held on 13.02.2026 at 04.00 p.m. and concluded at 05.00 p.m. inter-alia considered and approved the Standalone and approved the Standalone UFR for the quarter ended 31.12.2025 along with LRR thereon.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
77.64%
EBIT Growth (5y)
2.20%
EBIT to Interest (avg)
-2.02
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.71
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
10.03%
Institutional Holding
8.39%
ROCE (avg)
-8.32%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
21
Price to Book Value
3.21
EV to EBIT
-33.05
EV to EBITDA
-58.49
EV to Capital Employed
2.49
EV to Sales
3.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.49%
ROE (Latest)
-8.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

10.028

Mutual Funds

Held by 3 Schemes (0.0%)

FIIs

Held by 1 FIIs (8.39%)

Promoter with highest holding

Kesar Petroproducts Limited (27.59%)

Highest Public shareholder

Krish Pharma Speciality Private Limited- Escrow Demat Accoun (24.7%)

Individual Investors Holdings

7.82%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -100.00% vs 64.08% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -62.50% vs 29.41% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "10.37",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.08",
          "val2": "0.07",
          "chgp": "-214.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.39",
          "val2": "-0.24",
          "chgp": "-62.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.68%",
          "chgp": "-0.68%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.69",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.04",
          "val2": "-0.30",
          "chgp": "113.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.58",
          "val2": "-0.91",
          "chgp": "36.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.24%",
          "val2": "0.00%",
          "chgp": "0.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 23.62% vs 11.81% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.69",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.04",
          "val2": "-0.38",
          "chgp": "89.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.97",
          "val2": "-1.27",
          "chgp": "23.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.24%",
          "val2": "0.00%",
          "chgp": "-0.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.63% vs -0.64% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.39",
          "chgp": "-5.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.59",
          "val2": "-1.58",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
0.00
10.37
-100.00%
Operating Profit (PBDIT) excl Other Income
-0.08
0.07
-214.29%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.39
-0.24
-62.50%
Operating Profit Margin (Excl OI)
0.00%
0.68%
-0.68%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -100.00% vs 64.08% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -62.50% vs 29.41% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
16.69
0.00
Operating Profit (PBDIT) excl Other Income
0.04
-0.30
113.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.58
-0.91
36.26%
Operating Profit Margin (Excl OI)
0.24%
0.00%
0.24%
Values in Rs Cr.
Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
16.69
0.00
Operating Profit (PBDIT) excl Other Income
-0.04
-0.38
89.47%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.97
-1.27
23.62%
Operating Profit Margin (Excl OI)
-0.24%
0.00%
-0.24%
Values in Rs Cr.
Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 23.62% vs 11.81% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.41
-0.39
-5.13%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.59
-1.58
-0.63%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -0.63% vs -0.64% in Mar 2024

stock-summaryCompany CV
About Shreyas Intermediates Ltd stock-summary
stock-summary
Shreyas Intermediates Ltd
Micro Cap
Commodity Chemicals
Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992. The Company was promoted by Dinesh S Sharma. The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates.In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.
Company Coordinates stock-summary
Company Details
D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722
stock-summary
Tel: 91-2356-272471
stock-summary
accounts@shreyasintermediates.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai